Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Harvard Business School
Baxter
McKinsey

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Antroquinonol


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Antroquinonol?

Antroquinonol is an investigational drug.

There have been 10 clinical trials for Antroquinonol. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Dermatitis, and Hepatitis, Chronic. The leading clinical trial sponsors are Golden Biotechnology Corporation, PharmaNet, and ICON Clinical Research.

There are thirty-four US patents protecting this investigational drug and three hundred and forty-eight international patents.

Recent Clinical Trials for Antroquinonol
TitleSponsorPhase
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized PatientsGolden Biotechnology CorporationPhase 2
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult PatientsGolden Biotechnology CorporationPhase 2
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis BGolden Biotechnology CorporationPhase 2

See all Antroquinonol clinical trials

Clinical Trial Summary for Antroquinonol

Top disease conditions for Antroquinonol
Top clinical trial sponsors for Antroquinonol

See all Antroquinonol clinical trials

US Patents for Antroquinonol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Antroquinonol ⤷  Try it Free Method for the diagnosis, prognosis and treatment of lung cancer metastasis Fundacio Institut de Recerca Biomedica (IRB Barcelona) (Barcelona, ES) Institucio Catalana de Recerca I Estudis Avancats (Barcelona, ES) ⤷  Try it Free
Antroquinonol ⤷  Try it Free Gene fusions and gene variants associated with cancer LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA) ⤷  Try it Free
Antroquinonol ⤷  Try it Free Method for the diagnosis, prognosis and treatment of prostate cancer metastasis INBIOMOTION S.L. (Barcelona, ES) ⤷  Try it Free
Antroquinonol ⤷  Try it Free Method for the diagnosis, prognosis and treatment of prostate cancer metastasis InBioMotion S.L. (Barcelona, ES) ⤷  Try it Free
Antroquinonol ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Antroquinonol

Drugname Country Document Number Estimated Expiration Related US Patent
Antroquinonol Australia AU2013273242 2032-06-06 ⤷  Try it Free
Antroquinonol Australia AU2019204269 2032-06-06 ⤷  Try it Free
Antroquinonol Canada CA2875918 2032-06-06 ⤷  Try it Free
Antroquinonol China CN104603288 2032-06-06 ⤷  Try it Free
Antroquinonol Denmark DK2859120 2032-06-06 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Harvard Business School
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.